We are analyzing https://link.springer.com/article/10.1007/s00018-022-04563-0.

Title:
Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential | Cellular and Molecular Life Sciences
Description:
Rheumatoid arthritis (RA) is an autoimmune disease that mainly affects the joints but also leads to systemic inflammation. Auto-reactivity and dysregulation of self-tolerance are thought to play a vital role in disease onset. In the pathogenesis of autoimmune diseases, disturbed immunosuppressive properties of regulatory T cells contribute to the dysregulation of immune homeostasis. In RA patients, the functions of Treg cells and their frequency are reduced. Therefore, focusing on the re-establishment of self-tolerance by increasing Treg cell frequencies and preventing a loss of function is a promising strategy for the treatment of RA. This approach could be especially beneficial for those patients who do not respond well to current therapies. In this review, we summarize and discuss the current knowledge about the function, differentiation and regulation of Treg cells in RA patients and in animal models of autoimmune arthritis. In addition, we highlight the therapeutic potential as well as the challenges of Treg cell targeting treatment strategies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Health & Fitness
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cells, pubmed, treg, article, google, scholar, cas, regulatory, cell, arthritis, foxp, central, immunol, patients, suppressive, autoimmune, function, mice, peripheral, rheumatoid, expression, blood, human, reported, vivo, development, immune, cdcd, clinical, transfer, effector, disease, type, role, therapy, receptor, vitro, gene, med, cytokines, activation, functions, therapeutic, inflammation, shown, tgfbeta, expansion, trials, antigenspecific, mouse,

Topics {✒️}

steroid-refractory chronic graft-versus-host-disease reduce graft-versus-host reactions cells prevent graft-versus-host-disease killed anti-coii antibody-secreting g-protein-coupled adenosine receptors single-agent cytokine/antibody fusion cell–cell contact-mediated suppression cd28/ctla-4/b7 domains plays rapamycin-based gmp-compatible process regulatory t-cell responses short-chain fatty acids alloantigen-induced cd25+cd4+ regulatory direct cell-cell contact article download pdf forkhead/winged-helix protein cell contact-mediated suppression cell contact-dependent suppression p-selectin-dependent pathways anti-cd3/cd28 beads tag single-nucleotide polymorphisms antibody-cytokine immune complexes gmp-compatible protocol employing regulatory t-cell fate good manufacturing practice-compliant antigen-specific cd4+cd25+ tgf-beta-induced foxp3+ regulatory membrane-bound il-6r myeloid-derived suppressor cells antigen-specific treg cells stem cell-derived tissue cd4+cd25highcd127lowfoxp3+ cells remain cell contact-dependent immunosuppression vivo-expanded cd4+cd25+ immunoregulatory antigen-presenting dendritic cells efficient cell-based therapy il2ra/cd25 polymorphisms contribute promote t-regulatory cells regulating post-translational modification chimeric antigen receptors human anti-il-2 antibody anti-cd3 antibodies helps future treg-based therapies chimeric antigen receptor regulatory cell-mediated suppression long-lived il-2 mutein anti-tgf-beta antibodies [52] autoantibody-mediated autoimmune disease collagen-induced treg cells regulatory t-cell function regulatory t-cell induction

Questions {❓}

Dawson NAJ, Levings MK (2017) Antigen-specific regulatory T cells: are police CARs the answer?
De Curotto Lafaille MA, Lafaille JJ (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential
         description:Rheumatoid arthritis (RA) is an autoimmune disease that mainly affects the joints but also leads to systemic inflammation. Auto-reactivity and dysregulation of self-tolerance are thought to play a vital role in disease onset. In the pathogenesis of autoimmune diseases, disturbed immunosuppressive properties of regulatory T cells contribute to the dysregulation of immune homeostasis. In RA patients, the functions of Treg cells and their frequency are reduced. Therefore, focusing on the re-establishment of self-tolerance by increasing Treg cell frequencies and preventing a loss of function is a promising strategy for the treatment of RA. This approach could be especially beneficial for those patients who do not respond well to current therapies. In this review, we summarize and discuss the current knowledge about the function, differentiation and regulation of Treg cells in RA patients and in animal models of autoimmune arthritis. In addition, we highlight the therapeutic potential as well as the challenges of Treg cell targeting treatment strategies.
         datePublished:2022-09-29T00:00:00Z
         dateModified:2022-09-29T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00018-022-04563-0
         keywords:
            Regulatory T cells
            Chimeric antigen receptor
            CD4+ T cells
            Therapeutic potential
            Self-tolerance
            Autoimmunity
            Cell Biology
            Biomedicine
            general
            Life Sciences
            Biochemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04563-0/MediaObjects/18_2022_4563_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04563-0/MediaObjects/18_2022_4563_Fig2_HTML.png
         isPartOf:
            name:Cellular and Molecular Life Sciences
            issn:
               1420-9071
               1420-682X
            volumeNumber:79
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shuaifeng Yan
               affiliation:
                     name:University of Cologne
                     address:
                        name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
                     name:University of Cologne
                     address:
                        name:Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Konstantin Kotschenreuther
               affiliation:
                     name:University of Cologne
                     address:
                        name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shuya Deng
               affiliation:
                     name:University of Cologne
                     address:
                        name:Department of Ophthalmology, University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David M. Kofler
               url:http://orcid.org/0000-0001-6164-3980
               affiliation:
                     name:University of Cologne
                     address:
                        name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
                     name:Aachen Bonn Cologne Duesseldorf
                     address:
                        name:Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf, Cologne, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential
      description:Rheumatoid arthritis (RA) is an autoimmune disease that mainly affects the joints but also leads to systemic inflammation. Auto-reactivity and dysregulation of self-tolerance are thought to play a vital role in disease onset. In the pathogenesis of autoimmune diseases, disturbed immunosuppressive properties of regulatory T cells contribute to the dysregulation of immune homeostasis. In RA patients, the functions of Treg cells and their frequency are reduced. Therefore, focusing on the re-establishment of self-tolerance by increasing Treg cell frequencies and preventing a loss of function is a promising strategy for the treatment of RA. This approach could be especially beneficial for those patients who do not respond well to current therapies. In this review, we summarize and discuss the current knowledge about the function, differentiation and regulation of Treg cells in RA patients and in animal models of autoimmune arthritis. In addition, we highlight the therapeutic potential as well as the challenges of Treg cell targeting treatment strategies.
      datePublished:2022-09-29T00:00:00Z
      dateModified:2022-09-29T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00018-022-04563-0
      keywords:
         Regulatory T cells
         Chimeric antigen receptor
         CD4+ T cells
         Therapeutic potential
         Self-tolerance
         Autoimmunity
         Cell Biology
         Biomedicine
         general
         Life Sciences
         Biochemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04563-0/MediaObjects/18_2022_4563_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04563-0/MediaObjects/18_2022_4563_Fig2_HTML.png
      isPartOf:
         name:Cellular and Molecular Life Sciences
         issn:
            1420-9071
            1420-682X
         volumeNumber:79
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shuaifeng Yan
            affiliation:
                  name:University of Cologne
                  address:
                     name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
                  name:University of Cologne
                  address:
                     name:Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Konstantin Kotschenreuther
            affiliation:
                  name:University of Cologne
                  address:
                     name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shuya Deng
            affiliation:
                  name:University of Cologne
                  address:
                     name:Department of Ophthalmology, University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David M. Kofler
            url:http://orcid.org/0000-0001-6164-3980
            affiliation:
                  name:University of Cologne
                  address:
                     name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
                  name:Aachen Bonn Cologne Duesseldorf
                  address:
                     name:Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf, Cologne, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cellular and Molecular Life Sciences
      issn:
         1420-9071
         1420-682X
      volumeNumber:79
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Cologne
      address:
         name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
         type:PostalAddress
      name:University of Cologne
      address:
         name:Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
         type:PostalAddress
      name:University of Cologne
      address:
         name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
         type:PostalAddress
      name:University of Cologne
      address:
         name:Department of Ophthalmology, University of Cologne, Cologne, Germany
         type:PostalAddress
      name:University of Cologne
      address:
         name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
         type:PostalAddress
      name:Aachen Bonn Cologne Duesseldorf
      address:
         name:Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf, Cologne, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shuaifeng Yan
      affiliation:
            name:University of Cologne
            address:
               name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
            name:University of Cologne
            address:
               name:Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
      name:Konstantin Kotschenreuther
      affiliation:
            name:University of Cologne
            address:
               name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
      name:Shuya Deng
      affiliation:
            name:University of Cologne
            address:
               name:Department of Ophthalmology, University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
      name:David M. Kofler
      url:http://orcid.org/0000-0001-6164-3980
      affiliation:
            name:University of Cologne
            address:
               name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
            name:Aachen Bonn Cologne Duesseldorf
            address:
               name:Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf, Cologne, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
      name:Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
      name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
      name:Department of Ophthalmology, University of Cologne, Cologne, Germany
      name:Laboratory of Molecular Immunology, Division of Rheumatology and Clinical Immunology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
      name:Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf, Cologne, Germany

External Links {🔗}(615)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.11s.

LINK . SPRINGER . COM {}